Table 6 Comparison of cost-effectiveness (€) in " early " and " late " treatment groups
Early treatment | Late treatment | Difference | |
|---|---|---|---|
Primary Endpoint | |||
MV and/or death < 7 days, (%) | 21 | 63 | 42 |
Average cost per patient treated | |||
- surfactant (1st. dose) | 438.56 | 287.76 | 150.80 |
- surfactant (2nd. dose) | 19.93 | 23.98 | 4.05 |
- NCPAP | 4,334.36 | 4,389.08 | 54.72 |
- MV | 108.85 | 259.25 | 150.40 |
Total | 4,901.70 | 4,960.07 | 58.37 |